+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biochip Products Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

  • ID: 4719785
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 4

FEATURED COMPANIES

  • Fluidigm Corporation
  • GE Healthcare
  • HORIBA, Ltd.
  • Illumina, Inc.
  • QIAGEN
  • Roche Diagnostics
  • MORE
The report on the global biochip products market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global biochip products market to grow with a CAGR of 17.05% over the forecast period from 2018-2024. The study on biochip products market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on biochip products market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global biochip products market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global biochip products market over the period of 2016 to 2024. Further, the Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers
  • Technological Advances of Nanotechnology
  • Increasing Applications in Drug Discovery, Proteomics, and Genomics
  • Healthcare Expenditure Across Geographies
2. Restraints
  • Lack of Awareness About Biochip Technology
  • Fabrication of Biochips
3. Opportunities
  • Growing Applications of Biochip
Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segments Covered

The global biochip products market is segmented on the basis of product type, technology, and application.

The Global Biochip Products Market by Product Type
  • DNA Chips
  • Protein Chips
  • Lab-on-a-Chip
  • Others (Cell Arrays & Tissue Arrays)
The Global Biochip Products Market by Technology
  • Microfluidics
  • Microarray
The Global Biochip Products Market by Application
  • Genomics
  • Proteomics
  • Drug Discovery & Development
  • In-Vitro Diagnostics
Company Profiles

The companies covered in the report include:
  • Fluidigm Corporation
  • Life Technologies Corporation
  • Agilent Technologies, Inc.
  • GE Healthcare
  • Thermo Fisher Scientific Inc
  • Roche Diagnostics
  • HORIBA, Ltd.
  • QIAGEN
  • Illumina, Inc.
  • PerkinElmer, Inc.
What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the biochip products market.

2. Complete coverage of all the segments in the biochip products market to analyze the trends, developments in the global market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in the global biochip products market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Fluidigm Corporation
  • GE Healthcare
  • HORIBA, Ltd.
  • Illumina, Inc.
  • QIAGEN
  • Roche Diagnostics
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Biochip Products Market Highlights
2.2. Biochip Products Market Projection
2.3. Biochip Products Market Regional Highlights

3. Global Biochip Products Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Product Type
3.4.2. Growth Matrix Analysis by Technology
3.4.3. Growth Matrix Analysis by Application
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Biochip Products Market

4. Biochip Products Market Macro Indicator Analysis

5. Global Biochip Products Market by Product Type
5.1. DNA Chips
5.2. Protein Chips
5.3. Lab-on-a-Chip
5.4. Others (Cell Arrays & Tissue Arrays)

6. Global Biochip Products Market by Technology
6.1. Microfluidics
6.2. Microarray

7. Global Biochip Products Market by Application
7.1. Genomics
7.2. Proteomics
7.3. Drug Discovery & Development
7.4. In-Vitro Diagnostics

8. Global Biochip Products Market by Region 2018-2024
8.1. North America
8.1.1. North America Biochip Products Market by Product Type
8.1.2. North America Biochip Products Market by Technology
8.1.3. North America Biochip Products Market by Application
8.1.4. North America Biochip Products Market by Country
8.2. Europe
8.2.1. Europe Biochip Products Market by Product Type
8.2.2. Europe Biochip Products Market by Technology
8.2.3. Europe Biochip Products Market by Application
8.2.4. Europe Biochip Products Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Biochip Products Market by Product Type
8.3.2. Asia-Pacific Biochip Products Market by Technology
8.3.3. Asia-Pacific Biochip Products Market by Application
8.3.4. Asia-Pacific Biochip Products Market by Country
8.4. RoW
8.4.1. RoW Biochip Products Market by Product Type
8.4.2. RoW Biochip Products Market by Technology
8.4.3. RoW Biochip Products Market by Application
8.4.4. RoW Biochip Products Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Biochip Products Market
9.2. Companies Profiles
9.2.1. Fluidigm Corporation
9.2.1.1. Overview
9.2.1.2. Company Snapshot
9.2.1.3. Product Portfolio
9.2.1.4. Recent Developments
9.2.2. Life Technologies Corporation
9.2.2.1. Overview
9.2.2.2. Company Snapshot
9.2.2.3. Product Portfolio
9.2.2.4. Recent Developments
9.2.3. Agilent Technologies, Inc.
9.2.3.1. Overview
9.2.3.2. Company Snapshot
9.2.3.3. Financial Snapshot
9.2.3.4. Product Portfolio
9.2.3.5. Recent Developments
9.2.4. GE Healthcare
9.2.4.1. Overview
9.2.4.2. Company Snapshot
9.2.4.3. Financial Snapshot
9.2.4.4. Product Portfolio
9.2.4.5. Recent Developments
9.2.5. Thermo Fisher Scientific Inc
9.2.5.1. Overview
9.2.5.2. Company Snapshot
9.2.5.3. Financial Snapshot
9.2.5.4. Product Portfolio
9.2.5.5. Recent Developments
9.2.6. Roche Diagnostics
9.2.6.1. Overview
9.2.6.2. Company Snapshot
9.2.6.3. Financial Snapshot
9.2.6.4. Product Portfolio
9.2.6.5. Recent Developments
9.2.7. HORIBA, Ltd.
9.2.7.1. Overview
9.2.7.2. Company Snapshot
9.2.7.3. Product Portfolio
9.2.7.4. Recent Developments
9.2.8. QIAGEN
9.2.8.1. Overview
9.2.8.2. Company Snapshot
9.2.8.3. Financial Snapshot
9.2.8.4. Product Portfolio
9.2.8.5. Recent Developments
9.2.9. Illumina, Inc.
9.2.9.1. Overview
9.2.9.2. Company Snapshot
9.2.9.3. Product Portfolio
9.2.9.4. Recent Developments
9.2.10. PerkinElmer, Inc.
9.2.10.1. Overview
9.2.10.2. Company Snapshot
9.2.10.3. Financial Snapshot
9.2.10.4. Product Portfolio
9.2.10.5. Recent Developments

10. Appendix
10.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Fluidigm Corporation
  • Life Technologies Corporation
  • Agilent Technologies, Inc.
  • GE Healthcare
  • Thermo Fisher Scientific Inc
  • Roche Diagnostics
  • HORIBA, Ltd.
  • QIAGEN
  • Illumina, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4719785
Adroll
adroll